Fig. 2From: Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA studyBox plot showing global satisfaction. The box plot shows the changes over time in global satisfaction regarding the self-administration of pnf C1-INH (Berinert®), as reported in the TSQM surveys (medians in bold)Back to article page